Literature DB >> 19571734

Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease.

Maija Pihlajamäki1, Kelly O' Keefe, Lars Bertram, Rudolph E Tanzi, Bradford C Dickerson, Deborah Blacker, Marilyn S Albert, Reisa A Sperling.   

Abstract

The posteromedial cortices and other regions of the "default network" are particularly vulnerable to the pathology of Alzheimer disease (AD). In this study, we performed functional magnetic resonance imaging (fMRI) to investigate whether the presence of apolipoprotein E (APOE) epsilon allele and degree of memory impairment were associated with the dysfunction of these brain regions. Seventy-five elderly subjects ranging from cognitively normal to mild AD, divided into epsilon carriers and noncarriers, underwent fMRI during a memory-encoding task. Across all subjects, posteromedial and ventral anterior cingulate cortices (key components of the default network) as well as right middle and inferior prefrontal regions demonstrated reduced task-induced deactivation in the epsilon carriers relative to noncarriers. Even among cognitively normal subjects, epsilon carriers demonstrated reduced posteromedial deactivation compared with the noncarriers in the same regions which demonstrated failure of deactivation in AD patients. Greater failure of posteromedial deactivation was related to worse memory performance (delayed recall) across all subjects and within the range of cognitively normal subjects. In summary, the posteromedial cortical fMRI response pattern is modulated both by the presence of APOE epsilon and episodic memory capability. Altered fMRI activity of the posteromedial areas of the brain default network may be an early indicator of risk for AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19571734      PMCID: PMC2837131          DOI: 10.1097/WAD.0b013e3181a785c9

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  54 in total

1.  Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.

Authors:  K Meguro; X Blaizot; Y Kondoh; C Le Mestric; J C Baron; C Chavoix
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Encoding novel face-name associations: a functional MRI study.

Authors:  R A Sperling; J F Bates; A J Cocchiarella; D L Schacter; B R Rosen; M S Albert
Journal:  Hum Brain Mapp       Date:  2001-11       Impact factor: 5.038

3.  When zero is not zero: the problem of ambiguous baseline conditions in fMRI.

Authors:  C E Stark; L R Squire
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

4.  Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response.

Authors:  S Duke Han; Wes S Houston; Amy J Jak; Lisa T Eyler; Bonnie J Nagel; Adam S Fleisher; Gregory G Brown; Jody Corey-Bloom; David P Salmon; Leon J Thal; Mark W Bondi
Journal:  Neurobiol Aging       Date:  2006-01-24       Impact factor: 4.673

5.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

6.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

7.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

8.  Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment.

Authors:  S C Johnson; T W Schmitz; C H Moritz; M E Meyerand; H A Rowley; A L Alexander; K W Hansen; C E Gleason; C M Carlsson; M L Ries; S Asthana; K Chen; E M Reiman; G E Alexander
Journal:  Neurobiol Aging       Date:  2005-10-13       Impact factor: 4.673

9.  Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment.

Authors:  Yongxia Zhou; John H Dougherty; Karl F Hubner; Bing Bai; Rex L Cannon; R Kent Hutson
Journal:  Alzheimers Dement       Date:  2008-07       Impact factor: 21.566

10.  Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment.

Authors:  Anne Hämäläinen; Susanna Tervo; Marta Grau-Olivares; Eini Niskanen; Corina Pennanen; Jari Huuskonen; Miia Kivipelto; Tuomo Hänninen; Mia Tapiola; Matti Vanhanen; Merja Hallikainen; Eeva-Liisa Helkala; Aulikki Nissinen; Ritva Vanninen; Hilkka Soininen
Journal:  Neuroimage       Date:  2007-06-29       Impact factor: 6.556

View more
  38 in total

Review 1.  Potential of functional MRI as a biomarker in early Alzheimer's disease.

Authors:  Reisa Sperling
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Interactive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy elders.

Authors:  J Carson Smith; Kristy A Nielson; John L Woodard; Michael Seidenberg; Sally Durgerian; Piero Antuono; Alissa M Butts; Nathan C Hantke; Melissa A Lancaster; Stephen M Rao
Journal:  Neuroimage       Date:  2010-08-05       Impact factor: 6.556

3.  The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults.

Authors:  Patrizia Vannini; Trey Hedden; Willem Huijbers; Andrew Ward; Keith A Johnson; Reisa A Sperling
Journal:  Cereb Cortex       Date:  2012-05-14       Impact factor: 5.357

4.  Intrinsic connectivity between the hippocampus and posteromedial cortex predicts memory performance in cognitively intact older individuals.

Authors:  Liang Wang; Peter Laviolette; Kelly O'Keefe; Deepti Putcha; Akram Bakkour; Koene R A Van Dijk; Maija Pihlajamäki; Bradford C Dickerson; Reisa A Sperling
Journal:  Neuroimage       Date:  2010-02-24       Impact factor: 6.556

Review 5.  Dementia and the default mode.

Authors:  L L Beason-Held
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

Review 6.  Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.

Authors:  Goran Papenberg; Alireza Salami; Jonas Persson; Ulman Lindenberger; Lars Bäckman
Journal:  Neuropsychol Rev       Date:  2015-02-10       Impact factor: 7.444

7.  What goes down must come up: role of the posteromedial cortices in encoding and retrieval.

Authors:  P Vannini; J O'Brien; K O'Keefe; M Pihlajamäki; P Laviolette; R A Sperling
Journal:  Cereb Cortex       Date:  2010-04-02       Impact factor: 5.357

8.  Differential functional response in the posteromedial cortices and hippocampus to stimulus repetition during successful memory encoding.

Authors:  Patrizia Vannini; Trey Hedden; Caroline Sullivan; Reisa A Sperling
Journal:  Hum Brain Mapp       Date:  2012-02-17       Impact factor: 5.038

9.  Increased fMRI signal with age in familial Alzheimer's disease mutation carriers.

Authors:  Meredith N Braskie; Luis D Medina; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Miguel Angel Macias-Islas; Jeffrey L Cummings; Susan Y Bookheimer; John M Ringman
Journal:  Neurobiol Aging       Date:  2010-12-03       Impact factor: 4.673

10.  Differences in brain activity during a verbal associative memory encoding task in high- and low-fit adolescents.

Authors:  Megan M Herting; Bonnie J Nagel
Journal:  J Cogn Neurosci       Date:  2012-12-18       Impact factor: 3.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.